ストックスクリーナーアプリを入手
12.99
8.16%
0.98
アフターアワーズ：
13.15
0.16
+1.23%
前日終値:
$12.01
開ける：
$12.13
24時間の取引高:
1.31M
Relative Volume:
0.82
時価総額：
$611.69M
収益：
$217.11M
当期純損益:
$-651.19M
株価収益率:
-1.00
EPS:
-12.99
ネットキャッシュフロー:
$-387.26M
1週間 パフォーマンス:
-4.27%
1か月 パフォーマンス:
-10.91%
6か月 パフォーマンス:
+76.26%
1年 パフォーマンス:
+70.47%
1日の値動き範囲:
$12.10
$13.18
1週間の範囲:
$11.83
$13.75
52週間の値動き範囲:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
名前
Ginkgo Bioworks Holdings Inc
セクター
電話
(877) 442-5362
住所
27 DRYDOCK AVENUE, BOSTON
DNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
12.99 | 710.99M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-15 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-05-10 | ダウングレード | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-02 | ダウングレード | Goldman | Neutral → Sell |
| 2023-05-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | 開始されました | Berenberg | Buy |
| 2022-10-04 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-05-18 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-03-02 | 再開されました | Cowen | Outperform |
| 2022-02-23 | 開始されました | Goldman | Neutral |
| 2022-02-01 | 開始されました | BofA Securities | Neutral |
| 2022-01-28 | 開始されました | BofA Securities | Buy |
| 2022-01-07 | 開始されました | BTIG Research | Buy |
| 2021-11-29 | 開始されました | Jefferies | Buy |
| 2021-10-13 | 開始されました | Raymond James | Outperform |
| 2021-10-12 | 開始されました | William Blair | Outperform |
| 2021-09-20 | 開始されました | HSBC Securities | Buy |
すべてを表示
Ginkgo Bioworks Holdings Inc (DNA) 最新ニュース
Is Ginkgo Bioworks Holdings Inc. stock dividend yield sustainableQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Is Ginkgo Bioworks Holdings Inc. Class stock a defensive play amid uncertaintyWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Statistical indicators supporting Ginkgo Bioworks Holdings Inc.’s strengthBear Alert & Verified Swing Trading Watchlists - newser.com
Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat
Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declines2025 Market Outlook & Low Risk Profit Maximizing Plans - newser.com
Why Ginkgo Bioworks Holdings Inc. Class stock fits value portfoliosSwing Trade & Safe Investment Capital Preservation Plans - newser.com
Ginkgo Bioworks Holdings, Inc. (DNA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Ginkgo Bioworks Announces Date of First Quarter 2024 Results Pre - GuruFocus
Ginkgo Bioworks (NYSE:DNA) Shares Up 9.2%Here's What Happened - MarketBeat
Using Python tools to backtest Ginkgo Bioworks Holdings Inc. strategiesInsider Selling & Low Risk High Win Rate Stock Picks - newser.com
Will Ginkgo Bioworks Holdings Inc. Class stock announce a stock split2025 Volatility Report & Safe Capital Growth Plans - newser.com
Published on: 2025-11-01 08:58:08 - newser.com
Live market analysis of Ginkgo Bioworks Holdings Inc.Quarterly Trade Report & AI Driven Stock Movement Reports - newser.com
Ginkgo Bioworks stock surges after extending Bayer partnership By Investing.com - Investing.com Canada
Ginkgo Bioworks, Bayer extend partnership for agricultural biologicals By Investing.com - Investing.com Canada
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture - MarketScreener
Will Ginkgo Bioworks Holdings Inc. continue its uptrendWeekly Earnings Recap & Low Drawdown Momentum Ideas - newser.com
Ginkgo Bioworks (NYSE: DNA) extends Bayer alliance to develop microbial nitrogen fixation - Stock Titan
How interest rate cuts could boost Ginkgo Bioworks Holdings Inc. stockRecession Risk & Fast Exit/Entry Strategy Plans - newser.com
Real time pattern detection on Ginkgo Bioworks Holdings Inc. stockTrade Exit Summary & Consistent Return Investment Signals - newser.com
How sentiment analysis helps forecast Ginkgo Bioworks Holdings Inc.July 2025 Fed Impact & Consistent Profit Focused Trading Strategies - newser.com
Visual trend scoring systems applied to Ginkgo Bioworks Holdings Inc.Earnings Overview Report & Safe Entry Momentum Stock Tips - newser.com
Is Ginkgo Bioworks Holdings Inc. stock oversold or undervaluedEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
Can Ginkgo Bioworks Holdings Inc. stock beat market expectations this quarterJuly 2025 Spike Watch & Long-Term Safe Return Strategies - newser.com
Published on: 2025-10-31 02:21:27 - newser.com
Can Ginkgo Bioworks Holdings Inc. stock surprise with earnings upside2025 Top Decliners & Long-Term Safe Investment Plans - newser.com
Published on: 2025-10-30 23:28:20 - newser.com
Ginkgo Bioworks (NYSE: DNA) to host quarterly results Q&A Nov. 6 at 4:30 p.m. ET - Stock Titan
Ginkgo Bioworks Holdings Inc (DNA) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
0.21%
大文字化:
|
ボリューム (24 時間):